The effectiveness of post-discharge navigation added to an inpatient addiction consultation for patients with substance use disorder; a randomized controlled trial

被引:13
作者
Wakeman, Sarah E. [1 ,2 ]
Rigotti, Nancy A. [1 ,2 ]
Herman, Grace E. [3 ]
Regan, Susan [1 ,2 ]
Chang, Yuchiao [1 ,2 ]
Snow, Rachel [3 ]
Isenberg, Benjamin [3 ]
Metlay, Joshua P. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Div Gen Internal Med, 55 Fruit St,Founders 860, Boston, MA 02114 USA
[2] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA
关键词
Addiction consultation; addiction consult team; post-discharge navigation; substance use disorder; addiction; navigator; HOSPITALIZED-PATIENTS; DEPENDENCE; DISCHARGE; DEATH;
D O I
10.1080/08897077.2020.1809608
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background It is unknown whether post-discharge navigation enhances the impact of hospital-initiated addiction care. This study tested the incremental benefit of telephonic linkage to a post-discharge navigator for patients who received an addiction consultation during hospitalization.Methods:A two-arm, randomized controlled trial of 395 hospitalized adults with substance use disorder who received an addiction consultation. The intervention group received post-discharge phone calls from a navigator to review the recommended treatment plan and address barriers to engagement on days 3, 7, 14, and 21. The primary outcome was days of alcohol or drug use in the past 30 assessed by Timeline Follow-back at 1 month.Results: Follow-up assessment completion rates were 46% at 1 month, and 41%, at 2 months. At baseline, intervention and control groups did not differ in substance use patterns; 45% reported primary alcohol use, 43% drugs, and 12% both. Heroin was the most common drug. At baseline, mean days of past 30-day alcohol or drug use were 13.6 in the intervention and 14.9 in the control group. The median number of navigation calls completed was 3 out of 4. At 1 month, both groups reported less use (decrease of 4.8 in intervention vs. 4.2 days in control group,p = 0.49). There were no differences between groups at 2 months. Compared to controls, participants who received all four calls had a greater decrease in use with a mean 8.6 days decrease from baseline (difference of 4.4 days,p = 0.0009).Conclusion: Post-discharge telephonic patient navigation did not further improve substance use outcomes following addiction consultation.
引用
收藏
页码:646 / 653
页数:8
相关论文
共 22 条
  • [1] [Anonymous], 2019, KEY SUBSTANCE USE ME
  • [2] SmokefreeTXT for Homeless Smokers: Pilot Randomized Controlled Trial
    Baggett, Travis P.
    McGlave, Claire
    Kruse, Gina R.
    Yaqubi, Awesta
    Chang, Yuchiao
    Rigotti, Nancy A.
    [J]. JMIR MHEALTH AND UHEALTH, 2019, 7 (06):
  • [3] Impact of a Patient Navigator Program on Hospital-Based and Outpatient Utilization Over 180 Days in a Safety-Net Health System
    Balaban, Richard B.
    Zhang, Fang
    Vialle-Valentin, Catherine E.
    Galbraith, Alison A.
    Burns, Marguerite E.
    Larochelle, Marc R.
    Ross-Degnan, Dennis
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 (09) : 981 - 989
  • [4] High risk of overdose death following release from prison: variations in mortality during a 15-year observation period
    Bukten, Anne
    Stavseth, Marianne Riksheim
    Skurtveit, Svetlana
    Tverdal, Aage
    Strang, John
    Clausen, Thomas
    [J]. ADDICTION, 2017, 112 (08) : 1432 - 1439
  • [5] Predischarge Injectable Versus Oral Naltrexone to Improve Postdischarge Treatment Engagement Among Hospitalized Veterans with Alcohol Use Disorder: A Randomized Pilot Proof-of-Concept Study
    Busch, Angela Christina
    Denduluri, Meenakshi
    Glass, Joseph
    Hetzel, Scott
    Gugnani, Shalu P.
    Gassman, Michele
    Krahn, Dean
    Deyo, Brienna
    Brown, Randall
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 (07) : 1352 - 1360
  • [6] Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence A Randomized Clinical Trial
    D'Onofrio, Gail
    O'Connor, Patrick G.
    Pantalon, Michael V.
    Chawarski, Marek C.
    Busch, Susan H.
    Owens, Patricia H.
    Bernstein, Steven L.
    Fiellin, David A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (16): : 1636 - 1644
  • [7] Hedegaard Holly, 2018, NCHS Data Brief, P1, DOI 10.15620/cdc:101761
  • [8] Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances - Systematic review and meta-analysis
    Hjorthoj, Carsten Rygaard
    Hjorthoj, Anne Rygaard
    Nordentoft, Merete
    [J]. ADDICTIVE BEHAVIORS, 2012, 37 (03) : 225 - 233
  • [9] Don't Wanna Go Through That Madness No More: Quality of Life Satisfaction as Predictor of Sustained Remission from Illicit Drug Misuse
    Laudet, Alexandre B.
    Becker, Jeffrey B.
    White, William L.
    [J]. SUBSTANCE USE & MISUSE, 2009, 44 (02) : 227 - 252
  • [10] Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients A Randomized Clinical Trial
    Liebschutz, Jane M.
    Crooks, Denise
    Herman, Debra
    Anderson, Bradley
    Tsui, Judith
    Meshesha, Lidia Z.
    Dossabhoy, Shernaz
    Stein, Michael
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (08) : 1369 - 1376